Test Price
2,800 AED✅ Home Collection Available
AARS1 Gene Early Infantile Epileptic Encephalopathy Type 29 Genetic Test in UAE
2800 AED | 2026 DHA Guidelines
تحليل جين AARS1 للكشف عن الاعتلال الدماغي الصرعي المبكر من النوع 29 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
This state-of-the-art NGS test delivers definitive diagnosis for AARS1-related early infantile epileptic encephalopathy (EIEE29) with 99.9% diagnostic sensitivity under ISO 9001:2015 certified protocols. We provide hospital-grade home collection via cold-chain logistics (8 AM–11 PM), telephonic post-test clinical guidance, and direct insurance billing verification on WhatsApp.
تقدّم هذه الخدمة التشخيصية الدقيقة باستخدام تقنية التسلسل الجيني من الجيل التالي (NGS) لتأكيد الطفرات في جين AARS1 المرتبطة بالاعتلال الدماغي الصرعي المبكر من النوع 29. نلتزم بأعلى معايير الاعتماد والخصوصية وفقًا لقوانين الرعاية الصحية في دولة الإمارات، ونضمن جمع العينات منزليًا بسلاسل تبريد معتمدة ودعمًا استشاريًا ما بعد الفحص.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Certified Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
The AARS1 Gene NGS Test identifies pathogenic variants linked to Early Infantile Epileptic Encephalopathy Type 29, a severe neurodevelopmental disorder starting in infancy. This comprehensive assay analyses the entire coding region of the AARS1 gene, enabling precise clinical diagnosis and informed family planning.
| Parameter | Our Test | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Precision | 99.9% sensitivity for AARS1 variants | ~95% (lower depth for single gene) |
| Methodology | NGS + Sanger confirmation | NGS only; often requires secondary confirmation |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Interpretation | Dedicated genetic counsellor report | Broad report with incidental findings |
Physician Insight & Safety Protocol
“As a clinician, I understand the overwhelming journey families face when a child presents with early-onset seizures. This test provides a definitive molecular answer, but it must be integrated with a full clinical evaluation. I encourage parents to discuss results comprehensively with their neurologist or geneticist, as not all variants lead to the same disease severity.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
Medication Warning
Do not discontinue or adjust any prescribed antiepileptic medication without consulting your treating physician. Abrupt changes may precipitate life-threatening seizure exacerbation.
Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not indicated for asymptomatic adults without a family history; it requires pre-test genetic counselling and a suspected clinical phenotype. Minors must have legal guardian consent per UAE CDS Law 2026.
- ER Red Flags: Prolonged seizure (>5 minutes), respiratory distress, cyanosis, or altered consciousness require immediate emergency care — dial 998.
- Post-Test: Do not interpret results in isolation. Contact our helpline for clinical correlation.
Patient FAQ & Clinical Guidance
Q: How accurate is the AARS1 NGS test for diagnosing early infantile epileptic encephalopathy type 29?
Our assay achieves 99.9% diagnostic sensitivity by combining high-depth next-generation sequencing with Sanger confirmation of all detected variants, ensuring no pathogenic mutation is missed.
Q: Is home sample collection available and how is the sample handled?
Yes, our licensed phlebotomists perform hospital-grade venous blood collection at your doorstep between 8 AM and 11 PM, using a validated cold-chain system to preserve DNA integrity during transport.
Q: What do I need to prepare before the test?
A pre- genetic counselling session is mandatory to draw a detailed pedigree chart of family members affected by AARS1-related conditions. Provide the completed clinical history questionnaire and list all medications to your counsellor.
س: كم تبلغ دقة فحص جين AARS1 باستخدام تقنية NGS؟
يصل معدل الحساسية التشخيصية إلى 99.9% بفضل استخدام التسلسل العميق مع تأكيد سانجر لجميع الطفرات، مما يضمن تشخيصًا جزيئيًا دقيقًا.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians